Authors: Kieron D. Edwards, Anne Dubberke, Nadin Meyer, Simone Kugel, Juliane Hellhammer
Institutions: Sibelius Limited; daacro GmbH & Co. KG
Source: medRxiv. Posted May 30, 2021.
Objective: This study assesses the effects of SageXtra™: Sage, an extract of Salvia officinalis, on cognitive performance in adolescents (12-14 years old) and young adults (18-25 years old).
Methods and Findings: In a double-blind, placebo-controlled trial, participants received either 150 mg or 300 mg of SageXtra™: Sage. Cognitive performance was measured using CogTrack™, which evaluates attention, working memory, and episodic memory. A significant improvement was observed in the Immediate Word Recall task for young adults, indicating better episodic memory. There were no reported side effects.
Results: SageXtra™: Sage enhanced episodic memory in young adults, supporting its cognitive benefits. These results align with findings in older adults and suggest that further long-term studies could be valuable.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Back to Main Page